NCT03676621View on ClinicalTrials.gov

Buccal Misoprostol Versus IV Oxytocin in Prevention of Postpartum Hemorrhage

PHASE4CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

August 30, 2021

Study Completion Date

September 20, 2021

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Misoprostol

buccal tablets

DRUG

Oxytocin

intravenous drip

Trial Locations (1)

Unknown

Assiut Faculty of Medicine, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03676621 - Buccal Misoprostol Versus IV Oxytocin in Prevention of Postpartum Hemorrhage | Biotech Hunter | Biotech Hunter